Trials / Completed
CompletedNCT03534544
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 362 (actual)
- Sponsor
- Joslin Diabetes Center · Academic / Other
- Sex
- All
- Age
- 8 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will complete one study visit involving a semi-structured interview and surveys. The results of the study will be used to assist in the design of a new automated insulin delivery system.
Detailed description
Type 1 diabetes remains the most common chronic disease of childhood and affects millions of children and adults globally. The minority of persons with type 1 diabetes achieve the recommended glycemic targets. Currently approved and unapproved automated insulin delivery systems require patients to carry and wear multiple devices (pumps, tubing, blood glucose meters, mobile devices, etc.). There is a need to design automated insulin delivery systems that reduce the burden of diabetes management for young persons and their families in an effort to improve glycemic control as well as other biomedical and psychosocial outcomes. The purpose of this study is to conduct separate semi-structured interviews with young persons with type 1 diabetes and parents of youth with type 1 diabetes (not necessarily the parents of the youth participants) regarding their preferences for an automated, on-body insulin delivery system. Youth and parents will also complete short surveys related to perceived burden of diabetes self-care, quality of life, acceptance of diabetes, and worries about hypoglycemia. The feedback received from the interviews and surveys will help inform the design of a new on-body automated insulin delivery system.
Conditions
Timeline
- Start date
- 2018-08-23
- Primary completion
- 2019-12-17
- Completion
- 2019-12-17
- First posted
- 2018-05-23
- Last updated
- 2021-08-10
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03534544. Inclusion in this directory is not an endorsement.